focus -WSS

focus

author：fashion 2025-10-02 18:47:55 - browse：7991

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Information blocking fines are now fair game in health care

WSS

Listen: Who gets the credit for GLP

Why do women spend more than men on medical expenses?

Did you have Obamacare on your GOP debate bingo card?

Kaiser Permanente unions announce official strike date

FDA panel to weigh safety of artificial wombs for preterm births

Midwives could help bridge maternal health disparities in the U.S.

entertainment

focus

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Sudafed saga points to U.S. issues with evaluating older drugs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Sudafed saga points to U.S. issues with evaluating older drugs

How one medical school became remarkably diverse

Menendez indictment could see pharma lose a key ally

Alkermes shareholders re

Address the ethical violations that led to 'Three Identical Strangers'

ChatGPT in medicine: STAT answers readers' burning questions

Why do women spend more than men on medical expenses?

leisure time

Chamber of Commerce, DOJ clash in court over drug prices

Why do women spend more than men on medical expenses?

Listen: Who gets the credit for GLP

Sudafed saga points to U.S. issues with evaluating older drugs

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Senator probes 340B programs at Cleveland Clinic, Bon Secours

hotspot

focus

knowledge

hotspot